Advertisement

Aminocaproic Acid Injection

[27 January 2016]

Products Affected - Description

Aminocaproic Acid injection, Hospira
250 mg/mL, 20 mL vial, 25 count (NDC 00409-4346-73)

Reason for the Shortage

  • American Regent is not manufacturing aminocaproic acid injection at this time.
  • Hospira has aminocaproic acid on shortage due to manufacturing delays.

Available Products

There is insufficient supply for usual ordering.

Estimated Resupply Dates

Hospira has aminocaproic acid 250 mg/mL 20 mL vials available in limited supply.

Related Shortages

Updated

January 27, 2016, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement